
Articles
-
3 weeks ago |
aao.org | Mike Mott
APR 01, 2025 Advances in Imaging the Anterior Segment By Mike Mott, Contributing Writer Cornea/External Disease Advances in noninvasive imaging have improved the ability to visualize corneal structures and pathologies. An overview of several technologies.
-
Jan 1, 2025 |
aao.org | Mike Mott |Thomas Hwang |Suzann Pershing
Clinical Update JAN 01, 2025 By Mike Mott, interviewing Michael F. Chiang, MD; Thomas S. Hwang, MD; and Suzann Pershing, MD The promise of interoperability for image sharing, and why you should insist that your vendors comply with DICOM standards.
-
Sep 30, 2024 |
aao.org | Mike Mott
OCT 01, 2024 Enter AI By Mike Mott, Contributing Writer Glaucoma, Retina/Vitreous Artificial intelligence promises to make an impact across the spectrum of ophthalmic disease. Where does the technology stand today?
-
May 31, 2024 |
aao.org | Mike Mott
IOL Selection for Patients With Corneal Disease By Mike Mott, Contributing Writer Experts discuss considerations and controversies around selecting IOLs for patients with corneal disease, including keratoconus, Fuchs dystrophy, and dry eye.
-
Mar 31, 2024 |
aao.org | Mike Mott
The Anti-VEGF Question: What’s in Your Refrigerator? By Mike Mott With so many anti-VEGF drugs choices, retina specialists need to know how to stock their clinic refrigerators with biologic agents. EyeNet takes a look at the challenges underlying the decision-making process.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →